Order NO. D663227
ERBB2 抗原（多肽片段）
| 英文名 | ERBB2 Antigen (Peptide fragment) | ||
| 相關類別 | 抗原 | 儲存 | 冷凍（-20℃） |
|
|||
| 編 號 | 包裝 | 庫存 | 目錄價（￥） | 您的價格（￥） | 數 量 |
| D663227-0001 | 1 MG | 預計30日內發貨 |
|
|
|
產品描述
概述
Synthetic peptide corresponding to a region derived from 1240-1255 amino acids of human ERBB2
屬性
| Full name | erb-b2 receptor tyrosine kinase 2 |
| Synonyms | NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu |
| Swissprot | P04626 |
| Gene Accession | NP_004439 |
| Background | The ErbB2 (HER2) proto-oncogene encodes a 185 kDa transmembrane, receptor-like glycoprotein with intrinsic tyrosine kinase activity. While ErbB2 lacks an identified ligand, ErbB2 kinase activity can be activated in the absence of a ligand when overexpressed and through heteromeric associations with other ErbB family members. Amplification of the ErbB2 gene and overexpression of its product are detected in almost 40% of human breast cancers. Binding of the c-Cbl ubiquitin ligase to ErbB2 at Tyr1112 leads to ErbB2 poly-ubiquitination and enhances degradation of this kinase. ErbB2 is a key therapeutic target in the treatment of breast cancer and other carcinomas and targeting the regulation of ErbB2 degradation by the c-Cbl-regulated proteolytic pathway is one potential therapeutic strategy. Phosphorylation of the kinase domain residue Tyr877 of ErbB2 (homologous to Tyr416 of pp60c-Src) may be involved in regulating ErbB2 biological activity. The major autophosphorylation sites in ErbB2 are Tyr1248 and Tyr1221/1222; phosphorylation of these sites couples ErbB2 to the Ras-Raf-MAP kinase signal transduction pathway. |
相關文檔
|
||||